simIDM (Q79278): Difference between revisions
From MaRDI portal
Created a new Item |
Added link to MaRDI item. |
||||||||||||||
| (15 intermediate revisions by 4 users not shown) | |||||||||||||||
| Property / programmed in | |||||||||||||||
| Property / programmed in: R / rank | |||||||||||||||
| Property / last update | |||||||||||||||
| |||||||||||||||
| Property / last update: 27 January 2023 / rank | |||||||||||||||
| Property / author | |||||||||||||||
| Property / author: Alexandra Erdmann / rank | |||||||||||||||
| Property / author | |||||||||||||||
| Property / author: Kaspar Rufibach / rank | |||||||||||||||
| Property / copyright license | |||||||||||||||
| Property / copyright license: Apache License, Version 2.0 / rank | |||||||||||||||
| Property / depends on software | |||||||||||||||
| Property / depends on software: R / rank | |||||||||||||||
| Property / depends on software: R / qualifier | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: checkmate / rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: stats / rank | |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Joint modeling of progression‐free and overall survival and computation of correlation measures / rank | |||||||||||||||
| Property / software version identifier | |||||||||||||||
0.1.0 | |||||||||||||||
| Property / software version identifier: 0.1.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / software version identifier: 0.1.0 / qualifier | |||||||||||||||
publication date: 11 December 2023
| |||||||||||||||
| Property / programmed in | |||||||||||||||
| Property / programmed in: R / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / last update | |||||||||||||||
11 December 2023
| |||||||||||||||
| Property / last update: 11 December 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / description | |||||||||||||||
Based on the illness-death model a large number of clinical trials with oncology endpoints progression-free survival (PFS) and overall survival (OS) can be simulated, see Meller, Beyersmann and Rufibach (2019) <doi:10.1002/sim.8295>. The simulation set-up allows for random and event-driven censoring, an arbitrary number of treatment arms, staggered study entry and drop-out. Exponentially, Weibull and piecewise exponentially distributed survival times can be generated. The correlation between PFS and OS can be calculated. | |||||||||||||||
| Property / description: Based on the illness-death model a large number of clinical trials with oncology endpoints progression-free survival (PFS) and overall survival (OS) can be simulated, see Meller, Beyersmann and Rufibach (2019) <doi:10.1002/sim.8295>. The simulation set-up allows for random and event-driven censoring, an arbitrary number of treatment arms, staggered study entry and drop-out. Exponentially, Weibull and piecewise exponentially distributed survival times can be generated. The correlation between PFS and OS can be calculated. / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / author | |||||||||||||||
| Property / author: Alexandra Erdmann / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / author | |||||||||||||||
| Property / author: Kaspar Rufibach / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / author | |||||||||||||||
| Property / author: Holger Löwe / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / author | |||||||||||||||
| Property / author: Daniel Sabanés Bové / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / copyright license | |||||||||||||||
| Property / copyright license: Apache License, Version 2.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: checkmate / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: furrr / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: future / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: mstate / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: parallelly / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: stats / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / imports | |||||||||||||||
| Property / imports: survival / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / cites work | |||||||||||||||
| Property / cites work: Joint modeling of progression‐free and overall survival and computation of correlation measures / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / depends on software | |||||||||||||||
| Property / depends on software: R / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / depends on software: R / qualifier | |||||||||||||||
software version identifier: ≥ 3.6 | |||||||||||||||
| Property / MaRDI profile type | |||||||||||||||
| Property / MaRDI profile type: MaRDI software profile / rank | |||||||||||||||
Normal rank | |||||||||||||||
| links / mardi / name | links / mardi / name | ||||||||||||||
Latest revision as of 18:56, 12 March 2024
Simulating Oncology Trials using an Illness-Death Model
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | simIDM |
Simulating Oncology Trials using an Illness-Death Model |
Statements
11 December 2023
0 references
Based on the illness-death model a large number of clinical trials with oncology endpoints progression-free survival (PFS) and overall survival (OS) can be simulated, see Meller, Beyersmann and Rufibach (2019) <doi:10.1002/sim.8295>. The simulation set-up allows for random and event-driven censoring, an arbitrary number of treatment arms, staggered study entry and drop-out. Exponentially, Weibull and piecewise exponentially distributed survival times can be generated. The correlation between PFS and OS can be calculated.
0 references
